Maier Paul V Insider Trades

Insider Trading History

Track insider trading activity for Maier Paul V. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Eton Pharmaceuticals
Eton Pharmaceuticals ETON
Director
Holding Value $8.5M 294,253 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 7,757 shares
$15.47
$28.90
Eton Pharmaceuticals
Eton Pharmaceuticals ETON
Director
Holding Value $8.28M 286,496 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$189k 12,196 shares
$15.47
$28.90
Eton Pharmaceuticals
Eton Pharmaceuticals ETON
Director
Holding Value $723k 25,000 shares
Last Trade
Jan 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$325k 25,000 shares
$13.00
$28.90
Eton Pharmaceuticals
Eton Pharmaceuticals ETON
Director
Holding Value $4.76M 164,555 shares
Last Trade
Feb 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133k 30,000 shares
$4.42
$28.90
Ambrx Biopharma
Ambrx Biopharma AMAM
Director
Holding Value $2.38M 85,000 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.16M 85,000 shares
$13.68
$28.00
Eton Pharmaceuticals
Eton Pharmaceuticals ETON
Director
Holding Value $3.89M 134,555 shares
Last Trade
Mar 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$98k 25,000 shares
$3.92
$28.90
Ambrx Biopharma
Ambrx Biopharma AMAM
Director
Holding Value $5.88M 210,000 shares
Last Trade
Jan 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$614k 315,000 shares
$1.95
$28.00
Ambrx Biopharma
Ambrx Biopharma AMAM
Director
Holding Value $0 0 shares
Last Trade
Jan 27, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$614k 315,000 shares
$1.95
$28.00
Ambrx Biopharma
Ambrx Biopharma AMAM
Director
Holding Value $0 0 shares
Last Trade
Jan 01, 2023 Sale
$238k 105,000 shares
$2.27
$28.00
Eton Pharmaceuticals
Eton Pharmaceuticals ETON
Director
Holding Value $3.17M 109,555 shares
Last Trade
Feb 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$189k 50,000 shares
$3.78
$28.90
Eton Pharmaceuticals
Eton Pharmaceuticals ETON
Director
Holding Value $1.72M 59,555 shares
Last Trade
May 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$169k 19,655 shares
$8.61
$28.90
Eton Pharmaceuticals
Eton Pharmaceuticals ETON
Director
Holding Value $792k 27,400 shares
Last Trade
Mar 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$98.1k 27,400 shares
$3.58
$28.90
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Director
Holding Value $38.5k 12,000 shares
Last Trade
Jan 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.5M 12,000 shares
$2,787.50
$3.21
Eton Pharmaceuticals
Eton Pharmaceuticals ETON
Director
Holding Value $361k 12,500 shares
Last Trade
Feb 20, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$91.4k 12,500 shares
$7.31
$28.90
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Director
Holding Value $48.2k 15,000 shares
Last Trade
Feb 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112M 15,000 shares
$7,497.50
$3.21
Eton Pharmaceuticals
Eton Pharmaceuticals ETON
Director
Holding Value $1.73M 59,745 shares
Last Trade
Nov 15, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$30k 5,000 shares
$6.00
$28.90
Eton Pharmaceuticals
Eton Pharmaceuticals ETON
Director
Holding Value $0 0 shares
Last Trade
Nov 09, 2018 Sale
No data
No data
$28.90
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Director
Holding Value $96.3k 30,000 shares
Last Trade
Jan 23, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.27B 30,000 shares
$42,375.00
$3.21
Seelos Therapeutics
Seelos Therapeutics SEEL
Director
Holding Value $13k 35,000 shares
Last Trade
Jan 04, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.52B 35,000 shares
$243,558.39
$0.37
Seelos Therapeutics
Seelos Therapeutics SEEL
Director
Holding Value $5.13k 13,854 shares
Last Trade
Jan 05, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.66B 11,250 shares
$147,751.06
$0.37

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up